Researchers are advancing NES/T hormonal gel and DMAU through clinical trials. These methods suppress sperm production via ...

Contraception is no longer just about preventing pregnancy. It has become central to women's health, career planning, and ...

Mohr Marketing’s “Medical-First” Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive ...

It’s high time to change this and focus on sexual and reproductive health for men. Every single unplanned pregnancy involves ...

Innocan Pharma Corporation ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has ...

Young girls and boys were urged to seek guidance, ask questions, and use the available health services at Rabie Ridge Clinic ...

Viatris Inc. (Nasdaq: VTRS) today announced robust financial results for the fourth quarter and full year 2025. The Company ...

Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound® (tirzepatide) to include the four-dose single-patient use KwikPen® that ...

Mpilo Central Hospital has intensified security measures following revelations of widespread theft of medicines, food and ...

Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...

The panel heard that in November alone, some 263,000 prescriptions for Mounjaro were issued at a cost to the NHS of £60 million.

Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively Target guidance of approxima ...